Modern Love in miniature, featuring reader-submitted stories of no more than 100 words.

Genomic research of Fusobacterium nucleatum isolated from colon cancer tumors may help researchers develop future screening tests and cancer vaccines

Neurons get a lot of attention—but researchers think this star-shaped brain cell type could hold the key to treating some disorders.

Current drug delivery systems for cardiac diseases lack spatial control and reliable drug release processes. This fillable microrobotic system provides tunable drug release based on a thermosensiti...

Mucus keeps the microbiome healthy. Now scientists have clues about how it stops good microbes from going bad.

Scientists are developing vaccines to target the virus family that spawned Covid-19. Their efforts could thwart future variants, or even new related viruses.

If cellular rejuvenation technologies were available today, should those content with their final years care enough to use it?

Scientists are getting closer to understanding the neurology behind the memory problems and cognitive fuzziness that an infection can trigger.

Two new studies use whole genome sequencing to explore how the animals have fared in warmer conditions, raising questions about climate and adaptation.

A new study shows that as temperatures drop, nasal cells release fewer of the tiny protectors that bind and neutralize invading germs.

Getting a scan usually means a visit to a doctor and some giant equipment. What if that gear was wearable?

These cells—and the way they reawaken—can tell biologists quite a lot about life, death, and the gray zone in between.

Cori's work determined glycogen storage "disease" had several subtypes, each with a unique molecular cause

The xkcd author and former NASA engineer tackles our questions about science education, solvable climate issues, and his latest What If? book.

An infection can upset your microbiome, and if certain gut fungi run riot, this can kick the immune system into overdrive.

The ability to utilize one protein degrader against a whole host of diseases drives Kymera’s strategy when choosing protein targets.

Researchers have found a new way to keep records of when a cell’s genes turn on and off—by harnessing systems that bacteria already use for self-defense.

Modifying markers on DNA allows scientists to lower cholesterol levels in mice, even long-term.

Scientists say a mild Covid infection increased immune benefits from a later flu vaccine, but with a biological twist.

By tinkering with branched mRNA structures, scientists lay the groundwork to build better vaccines in the future. 

Sea cucumbers are squishy and soft. They also employ lethal strategies to protect themselves.

Researchers pioneered a new strategy for diagnosing puzzling genetic diseases, expanding scientists’ capability to study their causes and pathophysiology.

Viral diseases like hepatitis don’t have many successful treatments available, so scientists are engineering antibodies to try and change that.

Immune cells called monocytes are triggered to help clear infection—but in some cases they never switch off, leaving patients breathless for months.

Stimulating the frontal lobes of sleeping epilepsy patients improved their recall of information—and may one day help treat Parkinson’s or Alzheimer’s.

According to researchers at the Universite Sorbonne Paris Nord, Universite Paris-Saclay, ants can be trained to sniff out the specific odors associated with certain cancers.

Scientists created a pill that, when swallowed, collects snapshots of the gastrointestinal microbiome, revealing striking differences along the GI tract.

Audiology screening can be inaccessible for kids in low-resource areas. By utilizing off-the-shelf products, these scientists are trying to change that.

While weight-loss drugs are dialing down the urge to eat for many, others desperately need something that can convince their body to consume more.

At the University of Southern California, Dr. Eun Ji Chung and Dr. Mitchell Gross are tackling cancer at the nanoscale.

Updating the shots to adapt to rapidly changing variants is easier said than done, even with new mRNA technology.

Part of the difficulty of treating breast cancer is the genomic variability of the patient population, as well as the different forms the cancer can take.

The company’s overarching aim is to edit and equip cells with molecular tools, through CRISPR, to eliminate certain cancers.

A tickborne virus uses cholesterol receptors to worm its way into the cell.

For decades, researchers have tried to craft a successful vaccine for HIV. mRNA vaccines may offer the answer.

A “universal” shot would protect against every branch of Covid’s viral family tree—even future ones. But getting there won’t be easy.

A prosthetic arm that connects directly to the nervous system gives the user fine control over the motions of individual fingers—just by thinking and trying to move.

Deepcell, a biotechnology company spun out of Stanford University in 2017, focuses on quantifying and understanding morphology – part of the cell’s phenotype.

A team of researchers has developed an mRNA-based Lyme vaccine that aims to prevent Lyme disease by deterring the tick itself. And here's how effective it is.

Levitt has practiced law for over 20 years in the FDA regulatory space. Previously chief regulatory counsel for Pfizer Inc., Levitt has had extensive experience working with an interdisciplinary team...

This newfound ability to take tumor cells directly from a patient and incorporate them into a more clinically accurate glioblastoma model could lead to greater patient personalization in cancer...